Certain Type of Breast Cancer Drug Shows Better Result in Study.

Cites the results of the study on anticancer drug performance by lead researcher Anthony Howell of the University of Manchester in England financed by AstraZeneca PLC. Revelation of the effectiveness of aromatse inhibitors against breast cancer recurrence in women past menopause compared to tamoxifen; Basis of the conclusion on a five year study of thousands of women from 20 countries; Conduction of additional studies on the effectiveness of taking both drugs sequentially; Types of aromatase inhibitors available on the market from Novartis and Pfizer.